Altropane ( DrugBank: Altropane )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
6パーキンソン病2

6. パーキンソン病


臨床試験数 : 2,307 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05636852
(ClinicalTrials.gov)
March 31, 20231/11/2022Altropane Dose for Imaging Patients With Suspected Parkinson's DiseaseAn Open-label Multicenter Phase 2 Dose-evaluation Study of Altropane (123I) Injection for Striatal Dopamine Transporter Visualization Using SPECT Brain ImagingParkinson Disease;Movement DisordersDrug: Altropane (123I) InjectionGE HealthcareLabcorp Drug Development IncNot yet recruiting18 YearsN/AAll30Phase 2NULL
2NCT00397228
(ClinicalTrials.gov)
November 20066/11/2006ALTROPANE® SPECT Imaging in Patients With Parkinson DiseaseOptimizing the Performance of ALTROPANE® SPECT Imaging in Patients With Parkinson DiseaseParkinson DiseaseDrug: ALTROPANE®Molecular NeuroImagingInstitute for Neurodegenerative DisordersCompleted30 YearsN/ABoth27Phase 2United States